Bayer Spring Investor Conference March 16 Will Stress 2004 Financial Upturn
This article was originally published in The Pink Sheet Daily
Executive Summary
Restructuring is seen as a key factor in Bayer's improved performance. Its U.S. oncology business and ex-U.S. Levitra promotion are among likely topics for updates at the investor meeting.